Filed: 5/14/2025ACC: 0000904454-25-000272
📋 What this filing means
FINEPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $1.31B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$1.31B
Total AUM (reported)
40M
Total Shares
Allocation by class
TR UNIT$422.17M32.2%
COM NEW$353.18M26.9%
RUSSELL 2000 ETF$296.26M22.6%
COM$95.14M7.3%
COM SER C$45.01M3.4%
COM LBTY LIV S C$29.50M2.2%
SPONSORED ADR$28.03M2.1%
Portfolio Concentration
Top 3$1.05B80.1%
4–10$192.66M14.7%
11–25$68.85M5.3%
Top 3 weight
80.1%
Top 10 weight
94.7%
Voting Authority Distribution
Total shares with voting rights: 40M
Sole
Full voting authority
40M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
SPDR S&P 500 ETF TR
SOLEShares755K
TypeSH
Market value$422.17M
32.20%
Sole
755K
Shared
0.00
None
0.00
QXO INC
SOLEShares24.47M
TypeSH
Market value$331.30M
25.27%
Sole
24.47M
Shared
0.00
None
0.00
ISHARES TR
SOLEShares1.49M
TypeSH
Market value$296.26M
22.59%
Sole
1.49M
Shared
0.00
None
0.00
Liberty Broadband Corp
SOLEShares529.24K
TypeSH
Market value$45.01M
3.43%
Sole
529.24K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares728.60K
TypeSH
Market value$32.15M
2.45%
Sole
728.60K
Shared
0.00
None
0.00
LIBERTY MEDIA CORP DEL
SOLEShares432.89K
TypeSH
Market value$29.50M
2.25%
Sole
432.89K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares179.87K
TypeSH
Market value$28.03M
2.14%
Sole
179.87K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares691.26K
TypeSH
Market value$24.44M
1.86%
Sole
691.26K
Shared
0.00
None
0.00
MoonLake Immunotherapeutics
SOLEShares435.79K
TypeSH
Market value$17.03M
1.30%
Sole
435.79K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares656.59K
TypeSH
Market value$16.49M
1.26%
Sole
656.59K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares309.95K
TypeSH
Market value$12.46M
0.95%
Sole
309.95K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares380.70K
TypeSH
Market value$11.24M
0.86%
Sole
380.70K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares157.56K
TypeSH
Market value$10.06M
0.77%
Sole
157.56K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares640.07K
TypeSH
Market value$7.92M
0.60%
Sole
640.07K
Shared
0.00
None
0.00
XENCOR INC
SOLEShares642.20K
TypeSH
Market value$6.83M
0.52%
Sole
642.20K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.08M
TypeSH
Market value$5.86M
0.45%
Sole
1.08M
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares2.12M
TypeSH
Market value$5.55M
0.42%
Sole
2.12M
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares694.03K
TypeSH
Market value$4.87M
0.37%
Sole
694.03K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares961.25K
TypeSH
Market value$3.56M
0.27%
Sole
961.25K
Shared
0.00
None
0.00
ALEANNA INC
SOLEShares27.72K
TypeSH
Market value$208.7K
0.02%
Sole
27.72K
Shared
0.00
None
0.00
ALEANNA INC
SOLEShares490K
TypeSH
Market value$122.5K
<0.01%
Sole
490K
Shared
0.00
None
0.00
Marblegate Acquisition Corp
SOLEShares735K
TypeSH
Market value$117.6K
<0.01%
Sole
735K
Shared
0.00
None
0.00
MONEYHERO LIMITED
SOLEShares895K
TypeSH
Market value$32.8K
<0.01%
Sole
895K
Shared
0.00
None
0.00
LAKESHORE BIOPHARMA CO LTD
SOLEShares490K
TypeSH
Market value$20.2K
<0.01%
Sole
490K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares12.50K
TypeSH
Market value$7.1K
<0.01%
Sole
12.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 755K | SH | $422.17M 32.20% | 755K | 0.00 | 0.00 |
QXO INCSOLE | COM NEW | 24.47M | SH | $331.30M 25.27% | 24.47M | 0.00 | 0.00 |
ISHARES TRSOLE | RUSSELL 2000 ETF | 1.49M | SH | $296.26M 22.59% | 1.49M | 0.00 | 0.00 |
Liberty Broadband CorpSOLE | COM SER C | 529.24K | SH | $45.01M 3.43% | 529.24K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 728.60K | SH | $32.15M 2.45% | 728.60K | 0.00 | 0.00 |
LIBERTY MEDIA CORP DELSOLE | COM LBTY LIV S C | 432.89K | SH | $29.50M 2.25% | 432.89K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 179.87K | SH | $28.03M 2.14% | 179.87K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 691.26K | SH | $24.44M 1.86% | 691.26K | 0.00 | 0.00 |
MoonLake ImmunotherapeuticsSOLE | CLASS A ORD | 435.79K | SH | $17.03M 1.30% | 435.79K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 656.59K | SH | $16.49M 1.26% | 656.59K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 309.95K | SH | $12.46M 0.95% | 309.95K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 380.70K | SH | $11.24M 0.86% | 380.70K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 157.56K | SH | $10.06M 0.77% | 157.56K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 640.07K | SH | $7.92M 0.60% | 640.07K | 0.00 | 0.00 |
XENCOR INCSOLE | COM | 642.20K | SH | $6.83M 0.52% | 642.20K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.08M | SH | $5.86M 0.45% | 1.08M | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 2.12M | SH | $5.55M 0.42% | 2.12M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 694.03K | SH | $4.87M 0.37% | 694.03K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 961.25K | SH | $3.56M 0.27% | 961.25K | 0.00 | 0.00 |
ALEANNA INCSOLE | COM CL A | 27.72K | SH | $208.7K 0.02% | 27.72K | 0.00 | 0.00 |
ALEANNA INCSOLE | *W EXP 12/13/202 | 490K | SH | $122.5K <0.01% | 490K | 0.00 | 0.00 |
Marblegate Acquisition CorpSOLE | *W EXP 08/31/202 | 735K | SH | $117.6K <0.01% | 735K | 0.00 | 0.00 |
MONEYHERO LIMITEDSOLE | *W EXP 09/13/202 | 895K | SH | $32.8K <0.01% | 895K | 0.00 | 0.00 |
LAKESHORE BIOPHARMA CO LTDSOLE | *W EXP 03/15/202 | 490K | SH | $20.2K <0.01% | 490K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | COM NEW | 12.50K | SH | $7.1K <0.01% | 12.50K | 0.00 | 0.00 |